State-of-the-Art PaperThe Global Health and Economic Burden of Hospitalizations for Heart Failure: Lessons Learned From Hospitalized Heart Failure Registries
Key Words
Abbreviations and Acronyms
Cited by (0)
Dr. Fonarow has received research support from the National Heart, Lung, and Blood Institute (significant), Agency for Healthcare Research and Quality (significant), and Gambro (significant); and is a consultant for Novartis (significant), Medtronic (modest), and Johnson & Johnson (modest). Dr. Butler has received research support from the National Institutes of Health, Health Resources and Services Administration, European Commission, Amgen, Medtronic, Novartis, and Otsuka; and is a consultant for Alere, Bayer, BG Medicine, Celladon, CardioMEMS, Gambro, Medpace, Ono, Reate, Takeda, and Trevena. Dr. Lam has received research support from Boston Scientific, Medtronic, Vifor Pharma, and the National Medical Research Council of Singapore; and is a consultant for Bayer and Novartis. Dr. Sato has received research support from Roche Diagnostics Japan and Otsuka; and is a consultant for Novartis. Dr. Gheorghiade is a consultant for Abbott Laboratories, Astellas, AstraZeneca, Bayer Schering Pharma, Bayer HealthCare, Cardiorentis, CorThera, Cytokinetics, CytoPherx, DebioPharm, Errekappa Terapeutici, GlaxoSmithKline, Ikaria, Intersection Medical, Johnson & Johnson, Medtronic, Merck, Novartis Pharma, Ono Pharma USA, Otsuka Pharmaceuticals, Palatin Technologies, Pericor Therapeutics, Protein Design Laboratories, sanofi-aventis, Sigma Tau, Solvay Pharmaceuticals, Sticares InterACT, Takeda Pharmaceuticals, and Trevena Therapeutics. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.